baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Knock-Out BMRN/ DE000SW14525 /

2024-06-04 9:43:08 PM	Chg.-0.28	Bid10:00:37 PM	Ask10:00:37 PM	Underlying	Strike price	Expiration date	Option type
9.51EUR	-2.86%	- Bid Size: -	- Ask Size: -	BioMarin Pharmaceuti...	181.9067 USD	2078-12-31	Put

GlobeNewswire 05-28 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

GlobeNewswire 05-08 Terns Pharmaceuticals Announces Leadership Changes

GlobeNewswire 2023-11-02 California Life Sciences announces 20th annual Pantheon Award winners

GlobeNewswire 2023-10-02 California’s top scientific innovators selected as finalists for the 20th annual California Life Sci...

GlobeNewswire 2022-03-01 Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corpor...

GlobeNewswire 2022-02-14 Vaxart Appoints Edward Berg as Senior Vice President and General Counsel

Newsfile Corp 2022-02-04 SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioMarin Pharmaceutical Inc.

GlobeNewswire 2022-01-24 SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioMarin Pharmaceutical Inc.

GlobeNewswire 2021-12-23 Lifshitz Law Firm, P.C. Announces Investigations of Amarin Corporation plc (NASDAQGM: AMRN), BioMari...

GlobeNewswire 2021-12-21 BMRN FINAL DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioMarin Pharmaceutical Inc....

GlobeNewswire 2021-12-20 BMRN & RECAF – Upcoming Lead Deadlines: Bronstein, Gewirtz & Grossman, LLC

GlobeNewswire 2021-12-20 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

GlobeNewswire 2021-12-17 ROSEN, A LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure C...

GlobeNewswire 2021-12-07 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

GlobeNewswire 2021-12-07 ROSEN, A LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors to Secure Counsel Befor...

GlobeNewswire 2021-12-01 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

GlobeNewswire 2021-11-30 AMRN, BMRN & RECAF – Upcoming Class Actions Deadlines: Bronstein, Gewirtz & Grossman, LLC

GlobeNewswire 2021-11-28 ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losse...

GlobeNewswire 2021-11-19 AMRN, BMRN & RECAF – Class Actions Deadlines: Bronstein, Gewirtz & Grossman, LLC

GlobeNewswire 2021-11-15 Autolus Therapeutics announces the appointment of Dr. William D. Young as a Non-Executive Director

GlobeNewswire 2021-11-13 ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Lo...

GlobeNewswire 2021-11-12 AMRN, BMRN & RECAF – Class Action Alerts: Bronstein, Gewirtz & Grossman, LLC

GlobeNewswire 2021-11-10 INVESTOR REMINDER: BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) SHAREHOLDER CLASS ACTION DEADLINE- Be...

GlobeNewswire 2021-11-09 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

GlobeNewswire 2021-11-09 BIOMARIN DEADLINE ALERT: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Enco...

Soc. Generale Knock-Out BMRN/ DE000SW14525 /

If you wish to receive reply to your feedback, please provide your email address.